​
​

Iterum Therapeutics (ITRM) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Iterum Therapeutics Revenue Highlights

00

Iterum Therapeutics Revenue by Period

Iterum Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--100.00%
2019-12-31$37.00K-95.74%
2018-12-31$869.00K71.06%
2017-12-31$508.00K100.00%
2016-12-31--

Iterum Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Iterum Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$2.62M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30--100.00%
2019-03-31$37.00K-84.52%
2018-12-31$239.00K-5.91%
2018-09-30$254.00K37.30%
2018-06-30$185.00K-3.14%
2018-03-31$191.00K-45.27%
2017-12-31$349.00K119.50%
2017-09-30$159.00K100.00%
2017-06-30-100.00%
2017-03-31--

Iterum Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Iterum Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ONTXTraws Pharma$226.00B$56.00K
FBIOFortress Biotech$59.66M$13.03M
OCUPOcuphire Pharma$19.05M$1.11M
JAGXJaguar Health$9.76M$3.07M
TNXPTonix Pharmaceuticals$7.77M$2.82M
VRCAVerrica Pharmaceuticals$5.12M$-1.86M
AEZSCOSCIENS Biopharma$4.58M$3.98K
EYENEyenovia$3.79K$1.63K
REVBRevelation Biosciences--
FWBIEntero Therapeutics--
ADILAdial Pharmaceuticals--
DRMADermata Therapeutics--
HOTHHoth Therapeutics--
VINCVincerx Pharma--
CTXRCitius Pharmaceuticals--
CFRXContraFect--
ITRMIterum Therapeutics--
DFFNCervoMed--
ACSTAcasti Pharma--

ITRM Revenue FAQ

What is Iterum Therapeutics’s yearly revenue?

Iterum Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ITRM's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Iterum Therapeutics’s quarterly revenue?

Iterum Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.62M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). ITRM's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is Iterum Therapeutics’s revenue growth rate?

Iterum Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.